Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)

NCT07180147 is registered in ClinicalTrials.gov with Marymount University as lead sponsor.

NCT NCT07180147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07180147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)
Lead sponsor
Marymount University
Phase
Observational
Overall status
Active, not recruiting
Start date
May 1, 2025
Completion date
July 30, 2031
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease (ad), cardio vascular disease, disability physical, frailty syndrome, healthy aging, hypertension, metabolic syndrome (mets), mild cognitive impairment (mci), obesity & overweight